Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123905522 | 12390552 | 2 | F | 20160219 | 20160627 | 20160520 | 20160707 | EXP | PE-CELGENEUS-PER-2016054738 | CELGENE | 30.00 | YR | M | Y | 70.00000 | KG | 20160707 | OT | PE | PE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123905522 | 12390552 | 1 | PS | VIDAZA | AZACITIDINE | 1 | Intravenous drip | U | 50794 | INJECTION FOR INFUSION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123905522 | 12390552 | 1 | Myelodysplastic syndrome |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123905522 | 12390552 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123905522 | 12390552 | Sepsis | |
123905522 | 12390552 | Septic shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123905522 | 12390552 | 1 | 20160131 | 0 |